<DOC>
	<DOCNO>NCT00349115</DOCNO>
	<brief_summary>Multiple Myeloma incurable disease . Thalidomide combination agent currently trial newly diagnose patient , design treatment TCD , follow high dose chemotherapy autologous stem cell transplantation TD maintenance therapy patient newly diagnose multiple myeloma .</brief_summary>
	<brief_title>TCD Followed autoSCT Newly Diagnosed MM Patients</brief_title>
	<detailed_description>Phase II clinical trial patient newly diagnose . TCD ( thalidomide , cyclophosphamide dexamethasone ) apply patient induction chemotherapy , follow high dose chemotherpy autologous stem cell transplantation . Afterthen , receive TD ( thalidomide dexamethasone ) maintenance therapy one year .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>Newly diagnose multiple myeloma age 18 75 year old follow mesurable leisons : ( serum Mprotein ≥ 1 g/dL urine Mprotein ≥ 400 mg/day ) 1 . Smoldering indolent myeloma 2 . ECOG performance status &gt; 3 point 3 . Known hypersensitivity cyclphosphamide , thalidomide dexamethasone 4 . Peripheral neuropathy neuropathic pain Grade 2 high define NCI CTCAE version 3 5 . Uncontrolled severe cardiovascular disease , include MI within 6 month enrolment , New York Heart Association ( NYHA ) Class III IV heart failure , uncontrolled angina , clinically significant pericardial disease , cardiac amyloidosis , cardiac ejection fraction &lt; 0.5 : Severe conduction disorder : Hypotension ( sit systolic BP ≤ 100 mmHg and/or sit diastolic BP ≤ 60 mmHg 6 . Impaired hepatic function ( AST ALT ≥ x 3 upper normal , Tbilirubin ≥ x 2 upper normal ) 7 . Creatinine cliearance &lt; 20 ml/min 8 . Corrected serum calcium ≥ 14 mg/dL 9 . Sepsis current active infection 10 . Pregnancy breast feed 11 . Uncontrolled Diabetes Mellitus 12 . Previous history Recurrent DVT pulmonary embolism 13 . Active ulcer detect gastroscopy 14 . Serious medical psychiatric illness likely interfere participation clinical study . 15 . Receipt extensive radiation therapy within 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>